You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Filter by group:
Filter by availability:
Displaying drugs 1326 - 1350 of 2005 in total
DrugBank ID Name Weight StructureCategoriesTherapeutic Indication
DB00717
68-22-4
Norethisterone298.4192

C20H26O2
ThumbProgestins / Cytochrome P-450 CYP2C19 Inducers / Estren Derivatives / P-glycoprotein/ABCB1 Inducers / Combined Inducers of CYP3A4 and P-glycoprotein / Reproductive Control Agents / Steroids / Contraceptive Agents / Contraceptive Agents, Female / Norpregnenes / Norpregnanes / Norsteroids / Contraceptives, Oral / Contraceptives, Oral, Synthetic / Sex Hormones and Modulators of the Genital System / Hormonal Contraceptives for Systemic Use / Progestogens and Estrogens, Sequential Preparations / Genito Urinary System and Sex Hormones / Polycyclic Compounds / Hyperglycemia-Associated Agents / Cytochrome P-450 CYP3A4 Substrates / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Progestogens / Progestogens and estrogens, sequential preparations / Progestogens and estrogens, sequential preparationsFor the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic patholo...
DB01059
70458-96-7
Norfloxacin319.3308

C16H18FN3O3
ThumbCytochrome P-450 CYP2A6 Inhibitors / Anti-Infective Agents / Anti-Bacterial Agents / Heterocyclic Compounds, 2-Ring / Cytochrome P-450 Enzyme Inhibitors / Metabolic Side Effects of Drugs and Substances / Drug-Related Side Effects and Adverse Reactions / Chemically-Induced Disorders / Cytochrome P-450 CYP1A2 Inhibitors / Topoisomerase Inhibitors / Topoisomerase II Inhibitors / Quinolines / Fluoroquinolones / Quinolones / Antibacterials for Systemic Use / Antiinfectives / Quinolone Antibacterials / Enzyme Inhibitors / Cytochrome P-450 CYP3A Inhibitors / Combined Inhibitors of CYP3A4 and P-glycoprotein / QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) / Molecular Mechanisms of Pharmacological Action / Heterocyclic Compounds / Ophthalmologicals / Sensory Organs / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Antineoplastic Agents / Antiinfectives for Systemic Use / Fluoroquinolones / Combinations of antibacterialsFor the treatment of urinary tract infection
DB00957
35189-28-7
Norgestimate369.4971

C23H31NO3
ThumbReproductive Control Agents / Contraceptive Agents / Contraceptive Agents, Female / Contraceptives, Oral / Contraceptives, Oral, Synthetic / Sex Hormones and Modulators of the Genital System / Genito Urinary System and Sex Hormones / Hormonal Contraceptives for Systemic Use / Hyperglycemia-Associated Agents / CYP3A4 Inducers (Weak) / Physiological Effects of Drugs / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Progestogens and estrogens, fixed combinations / Progestogens and estrogens, fixed combinationsFor the prevention of pregnancy
DB09389
6533-00-2
Norgestrel312.453

C21H28O2
ThumbReproductive Control Agents / Contraceptive Agents / Contraceptive Agents, Female / Norpregnenes / Norpregnanes / Norsteroids / Contraceptives, Oral / Contraceptives, Oral, Synthetic / Sex Hormones and Modulators of the Genital System / Genito Urinary System and Sex Hormones / Hormonal Contraceptives for Systemic Use / Progestogens and Estrogens, Sequential Preparations / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Polycyclic Compounds / Steroids / Cytochrome P-450 CYP3A4 Substrates / Progestogens and estrogens, fixed combinations / Progestogens and estrogens, fixed combinationsNorgestrel in combination with ethinyl estradiol is indicated for the prevention of pregnancy in women who elect to use this product as a method of...
DB11609
467-85-6
Normethadone295.426

C20H25NO
ThumbAntitussive Agents / Opium Alkaloids and Derivatives / Cough and Cold Preparations / Analgesics / Central Nervous System Depressants / Narcotics / Analgesics, Opioid / Sensory System Agents / Central Nervous System Agents / Peripheral Nervous System Agents / Respiratory System Agents / Respiratory System / Physiological Effects of Drugs / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Opium alkaloids and derivativesNot Annotated
DB00540
72-69-5
Nortriptyline263.3767

C19H21N
ThumbCytochrome P-450 CYP2E1 Inhibitors / Alpha1 Antagonists / CYP2D6 Inhibitors (Weak) / Polycyclic Hydrocarbons, Aromatic / Adrenergic Uptake Inhibitors / Dibenzocycloheptenes / Benzocycloheptenes / Antidepressive Agents, Tricyclic / Non-Selective Monoamine Reuptake Inhibitors / QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) / Antidepressive Agents / Hydrocarbons, Aromatic / Neurotransmitter Uptake Inhibitors / Psychoanaleptics / Polycyclic Compounds / Hydrocarbons, Cyclic / Serotonin Modulators / Psychotropic Drugs / Membrane Transport Modulators / Cytochrome P-450 CYP2D6 Substrates / Hydrocarbons / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Inhibitors / Nervous System / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP3A4 Substrates / Molecular Mechanisms of Pharmacological Action / Neurotransmitter Agents / Adrenergic Agents / Organic Chemicals / Central Nervous System Depressants / Cytochrome P-450 CYP2C19 Substrates / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Central Nervous System Agents / Non-selective monoamine reuptake inhibitorsFor the treatment of depression, chronic pain, irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia, and migraine...
DB01051
303-81-1
Novobiocin612.6243

C31H36N2O11
ThumbNucleic Acid Synthesis Inhibitors / Coumarins / Aminocoumarins / BCRP/ABCG2 Inhibitors / BSEP/ABCB11 Inhibitors / Heterocyclic Compounds, 2-Ring / Benzopyrans / Pyrans / Heterocyclic Compounds, 1-Ring / Heterocyclic Compounds / Anti-Infective Agents / Anti-Bacterial Agents / Enzyme Inhibitors / Molecular Mechanisms of Pharmacological Action / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Carbohydrates / GlycosidesFor the treatment of infections due to staphylococci and other susceptible organisms
DB00646
1400-61-9
Nystatin926.0949

C47H75NO17
ThumbMolecular Mechanisms of Pharmacological Action / Membrane Transport Modulators / Ionophores / Dermatologicals / Antifungals for Topical Use / Antifungals for Dermatological Use / Antifungal Agents (Vaginal) / Specialty Uses of Chemicals / Genito Urinary System and Sex Hormones / Alimentary Tract and Metabolism / Gynecological Antiinfectives and Antiseptics / Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents / Intestinal Antiinfectives / Macrocyclic Compounds / Antifungal Agents / Macrolides / Polyketides / Lactones / Polycyclic Compounds / Anti-Bacterial Agents / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Anti-Infective Agents / Organic Chemicals / Antibiotics / AntibioticsFor treatment of cutaneous or mucocutaneous mycotic infections caused by Candida species
DB09496
OctinoxateNot AnnotatedThumbDermatologic Agents / Radiation-Protective Agents / Cosmetics / Household Products / Sunscreening Agents / Dermatologicals / Protectives Against Uv-Radiation / Emollients and Protectives / Protectives Against Uv-Radiation for Topical Use / Physiological Effects of Drugs / Protective Agents / Therapeutic Uses / Technology, Industry, and Agriculture / Pharmacologic Actions / Chemical Actions and Uses / Specialty Uses of Chemicals / Protectives against UV-radiation for topical useNot Annotated
DB11062
OctisalateNot AnnotatedThumbSunscreening AgentsNot Annotated
DB09535
OctocryleneNot AnnotatedThumbSunscreening AgentsNot Annotated
DB00104
83150-76-9
Octreotide1019.25

C49H66N10O10S2
ThumbAmino Acids, Peptides, and Proteins / Gastrointestinal Agents / Peptides / Hypothalamic Hormones / Antineoplastic Agents, Hormonal / Peptides, Cyclic / Somatostatin and Analogues / QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) / Hypoglycemia-Associated Agents / Blood Glucose Lowering Agents / Somatostatin Analogs / Bradycardia-Causing Agents / Pituitary and Hypothalamic Hormones and Analogues / Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins / Antineoplastic Agents / Macrocyclic Compounds / Hyperglycemia-Associated Agents / Polycyclic Compounds / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Somatostatin and analoguesFor treatment of acromegaly and reduction of side effects from cancer chemotherapy
DB01165
82419-36-1
Ofloxacin361.3675

C18H20FN3O4
ThumbCytochrome P-450 Enzyme Inhibitors / Metabolic Side Effects of Drugs and Substances / Drug-Related Side Effects and Adverse Reactions / Chemically-Induced Disorders / Cytochrome P-450 CYP1A2 Inhibitors / Renal Agents / Anti-Infective Agents, Urinary / Quinolines / Quinolones / Ophthalmologicals / Sensory Organs / Antiinfectives / Otologicals / Anti-Bacterial Agents / Topoisomerase Inhibitors / Topoisomerase II Inhibitors / Fluoroquinolones / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Quinolone Antibacterials / Moderate Risk QTc-Prolonging Agents / Antineoplastic Agents / Heterocyclic Compounds, 2-Ring / Anti-Infective Agents / Enzyme Inhibitors / Molecular Mechanisms of Pharmacological Action / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Heterocyclic Compounds / Fluoroquinolones / Combinations of antibacterialsFor the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.
DB00334
132539-06-1
Olanzapine312.432

C17H20N4S
ThumbMembrane Transport Modulators / Psychotropic Drugs / Tranquilizing Agents / Neurotransmitter Uptake Inhibitors / Serotonin Agents / Cytochrome P-450 CYP2C19 Inhibitors / Serotonin Uptake Inhibitors / Antiemetics / Cytochrome P-450 CYP2C9 Inhibitors / Antipsychotic Agents / Cytochrome P-450 CYP2D6 Inhibitors / Nervous System / Psycholeptics / Diazepines, Oxazepines, Thiazepines and Oxepines / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Alpha1 Antagonists / H2 Antagonists / Antiemetics Antagonists / Antipsychotic Agents (Second Generation [Atypical]) / Hyperglycemia-Associated Agents / CYP2D6 Inhibitors (Weak) / Cytochrome P-450 CYP3A Inhibitors / Combined Inhibitors of CYP3A4 and P-glycoprotein / Autonomic Agents / QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) / Molecular Mechanisms of Pharmacological Action / Neurotransmitter Agents / Central Nervous System Depressants / Peripheral Nervous System Agents / Central Nervous System Agents / Gastrointestinal Agents / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / P-glycoprotein/ABCB1 Substrates / Diazepines, oxazepines, thiazepines and oxepinesFor the acute and maintenance treatment of schizophrenia and related psychotic disorders, as well as acute treatment of manic or mixed episodes of ...
DB09074
763113-22-0
OlaparibNot AvailableThumbCytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP2B6 Inducers / Poly(ADP-ribose) Polymerase Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (moderate) / Combined Inhibitors of CYP3A4 and P-glycoprotein / Cytochrome P-450 CYP3A4 Substrates / Enzyme Inhibitors / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Myelosuppressive Agents / Molecular Mechanisms of Pharmacological Action / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Other antineoplastic agentsOlaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated as monotherapy in patients with deleterious or suspected deleterious germline...
DB04224
112-80-1
Oleic Acid282.4614

C18H34O2
ThumbFatty Acids, Unsaturated / Fatty Acids / Fatty Acids, Monounsaturated / Oleic Acids / Lipids
DB09567
Olive oilNot AnnotatedThumbBiological Products / Complex Mixtures / Lipids / Food / Food and Beverages / Diet, Food, and Nutrition / Physiological Phenomena / Dietary Fats, Unsaturated / Dietary Fats / Fats / Oils / Plant Oils / Plant Preparations / Fats, UnsaturatedNot Annotated
DB00275
144689-24-7
Olmesartan446.5016

C24H26N6O3
ThumbCardiovascular Agents / Heterocyclic Compounds, 1-Ring / Azoles / Imidazoles / Tetrazoles / Angiotensin Receptor Antagonists / Angiotensin II Type 1 Receptor Blockers / Antihypertensive Agents / Cardiovascular System / Angiotensin II Antagonists and Calcium Channel Blockers / Agents Acting on the Renin-Angiotensin System / Angiotensin II Antagonists and Diuretics / Angiotensin II Antagonists, Plain / OATP1B1/SLCO1B1 Substrates / Hypotensive Agents / Molecular Mechanisms of Pharmacological Action / Heterocyclic Compounds / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Angiotensin II antagonists and diuretics / Angiotensin II antagonists, plain / Angiotensin II antagonists, other combinations / Angiotensin II antagonists and calcium channel blockersFor the treatment of hypertension.
DB09080
868049-49-4
Olodaterol386.448

C21H26N2O5
ThumbRespiratory System Agents / Anti-Asthmatic Agents / Autonomic Agents / Adrenergic Agents / Adrenergic Agonists / Adrenergic beta-Agonists / Bronchodilator Agents / Adrenergic beta-1 Receptor Agonists / Respiratory System / Drugs for Obstructive Airway Diseases / Selective Beta-2-Adrenoreceptor Agonists / Adrenergics, Inhalants / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2C8 Substrates / Beta2 Agonists / QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) / Molecular Mechanisms of Pharmacological Action / Neurotransmitter Agents / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Peripheral Nervous System Agents / Adrenergics in combination with anticholinergics / Selective beta-2-adrenoreceptor agonistsOlodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated...
DB00768
113806-05-6
Olopatadine337.4122

C21H23NO3
ThumbMolecular Mechanisms of Pharmacological Action / Neurotransmitter Agents / Anti-Allergic Agents / Heterocyclic Compounds / Heterocyclic Compounds, 3-Ring / Central Nervous System Depressants / Histamine Agents / Histamine Antagonists / Histamine H1 Antagonists / Histamine H1 Antagonists, Non-Sedating / Dibenzoxepins / Ophthalmologicals / Sensory Organs / Respiratory System / Nasal Preparations / Decongestants and Antiallergics / Antiallergic Agents, Excl. Corticosteroids / Cytochrome P-450 CYP3A4 Substrates / Analgesics, Non-Narcotic / Analgesics / Sensory System Agents / Peripheral Nervous System Agents / Central Nervous System Agents / Antirheumatic Agents / Anti-Inflammatory Agents / Anti-Inflammatory Agents, Non-Steroidal / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Antiallergic agents, excl. corticosteroidsFor the treatment of ocular itching associated with allergic conjunctivitis.
DB01250
15722-48-2
Olsalazine302.239

C14H10N2O6
ThumbAnalgesics, Non-Narcotic / Analgesics / Sensory System Agents / Peripheral Nervous System Agents / Central Nervous System Agents / Antirheumatic Agents / Anti-Inflammatory Agents / Gastrointestinal Agents / Anti-Inflammatory Agents, Non-Steroidal / Alimentary Tract and Metabolism / Aminosalicylic Acid and Similar Agents / Intestinal Antiinflammatory Agents / Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Physiological Effects of Drugs / Aminosalicylic acid and similar agentsFor the treatment of Inflammatory Bowel Disease and Ulcerative Colitis.
DB04865
26833-87-4
Omacetaxine mepesuccinate545.6213

C29H39NO9
ThumbPhysiological Effects of Drugs / Angiogenesis Modulating Agents / Growth Substances / Growth Inhibitors / Angiogenesis Inhibitors / Antineoplastic Agents, Phytogenic / Apoptosis / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Pharmacologic Actions / Chemical Actions and Uses / Therapeutic Uses / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Other antineoplastic agentsUsed in patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.
DB09296
1258226-87-7
Ombitasvir894.127

C50H67N7O8
ThumbAntiviral Agents / Antiinfectives for Systemic Use / Direct Acting Antivirals / Antivirals for Systemic Use / Cytochrome P-450 CYP2C8 Substrates / P-glycoprotein/ABCB1 Substrates / Other antivirals / Other antiviralsWhen used within the fixed dose combination product of paritaprevir/ombitasvir/ritonavir (Technivie), ombitasvir is indicated in combination with r...
DB09539
Omega-3-acid ethyl estersNot AnnotatedThumbNot AnnotatedNot Annotated
DB09568
Omega-3-carboxylic acidsNot AnnotatedThumbNot AnnotatedNot Annotated
Displaying drugs 1326 - 1350 of 2005 in total